Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04892173
Title NBTXR3 With or Without Cetuximab in LA-HNSCC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Nanobiotix
Age Groups: senior
Covered Countries USA | FRA | ESP | DEU | CAN | BEL | AUT

No variant requirements are available.